Research progress of homocysteine in central nervous system disorders in the elderly
CSTR:
Author:
Affiliation:

(Jiangsu Health Development Research Center, NHC Key Laboratory of Contraceptives Vigilance and Fertility Surveillance, Jiangsu Provincial Key Laboratory of Fertility Protection and Health Technology Assessment, Nanjing 210036, China)

Clc Number:

Fund Project:

This work was supported by the General Program of Geriatric Health Research of Jiangsu Province(LKM2023025),the Improvement Project for Scientific Research and Education Capacities of Jiangsu Province(ZDXYS202210),and the General Program of Geriatric Health Research of Jiangsu Province(LKM2024022).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Homocysteine (Hcy) has been confirmed to be closely associated with various pathological conditions in epidemiological and clinical studies, including cardiovascular disease, neurological disorders, atherosclerosis, neural tube defects, diabetes mellitus, renal diseases, and certain tumors. In this article, we reviewed the research progress of Hcy in elderly central nervous system (CNS) diseases, such as Alzheimer′s disease, vascular dementia, Parkinson′s disease, ischemic stroke, and epilepsy, and explored its mechanisms of action and clinical significance, so as to provide new ideas for the prevention, diagnosis, treatment, and prognosis of these CNS disorders in the elderly.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 03,2025
  • Revised:
  • Adopted:
  • Online: November 26,2025
  • Published:
Article QR Code